1 in 3 with lupus takes supplements, medications with potential for interactions
Nearly 1 in 3 patients with systemic lupus erythematosus (SLE) are taking a supplement-medication combination with potential for an interaction, according to a study published online Sept. 22 in Arthritis Care & Research.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
When war hits the wallet, mental health can suffer too
United Kingdom
-
International consensus sets updated framework for CAR T-cell therapy in severe autoimmune diseases
United Kingdom
-
Abnormal lymph vessels show heightened growth signaling regardless of key gene mutation
United Kingdom
-
Pausing certain arthritis drugs after COVID-19 vaccination raises flare risk without improving antibody response
United Kingdom
-
HIV treatment has transformed lives in the UK, but stigma lingers
United Kingdom
-
Sickle cell pain may involve previously unrecognized biological pathways
United Kingdom
-
Early-onset menopause linked to increased symptoms of anxiety and depression
United Kingdom
-
PSMA PET/CT-targeted biopsy improves detection of clinically significant prostate cancer
United Kingdom